Deletion of CBFB in a patient with acute myelomonocytic leukemia (AML M4Eo) and inversion 16

被引:14
作者
Egan, N [1 ]
O'Reilly, J [1 ]
Chipper, L [1 ]
Higgins, M [1 ]
Herrmann, R [1 ]
Cannell, P [1 ]
机构
[1] Royal Perth Hosp, Dept Haematol, Perth, WA 6001, Australia
关键词
D O I
10.1016/j.cancergencyto.2004.01.022
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Acute myelomonocytic leukemia with bone marrow eosinophilia (AML M4Eo) is a subtype of AML with distinct morphological features. Inversion (16)(p13.1q22), t(16;16)(p13.1;q22), and del(16)(q22) are nonrandom abnormalities associated with AML M4Eo and a favorable prognosis, compared with the standard risk group for AML. Deletions of the proximal region of the MYH11 gene located at 16p13.1 have been detected in about 20% of patients with inv(16), with an undetermined effect on patient survival. We present the case of a patient with AML M4Eo and inversion 16 with a distal deletion of the CBFB gene at 16q22 detected with fluorescence in situ hybridization. To our knowledge, only one previous report of a similar deletion has appeared in the literature. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:60 / 62
页数:3
相关论文
共 13 条
[11]   Detection of 16 p deletions by FISH in patients with inv(16) or t(16;16) and acute myeloid leukemia (AML) [J].
Martinet, D ;
Muhlematter, D ;
Leeman, M ;
Parlier, V ;
Hess, U ;
Gmur, J ;
Jotterand, M .
LEUKEMIA, 1997, 11 (07) :964-970
[12]  
Mitelman F., 1995, SUPPLEMENT INT SYSTE
[13]   Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease -: Report of the BIOMED-1 Concerted Action:: Investigation of minimal residual disease in acute leukemia [J].
van Dongen, JJM ;
Macintyre, EA ;
Gabert, JA ;
Delabesse, E ;
Rossi, V ;
Saglio, G ;
Gottardi, E ;
Rambaldi, A ;
Dotti, G ;
Griesinger, F ;
Parreira, A ;
Gameiro, P ;
Diáz, MG ;
Malec, M ;
Langerak, AW ;
San Miguel, JF ;
Biondi, A .
LEUKEMIA, 1999, 13 (12) :1901-1928